| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,434 | 14,479 | 13,736 | 10,576 | | Cost of Revenue | 9,181 | 8,456 | 8,217 | 8,718 | | | Gross Profit | 6,253 | 6,023 | 5,519 | 1,857 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,845 | 2,700 | 2,805 | 1,966 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 457 | 739 | 171 | 80 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,239 | 3,155 | 2,544 | (189) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46 | 210 | (78) | (1,181) | | Earnings Before Interest And Taxes | 3,008 | 3,001 | 2,465 | (1,370) | | Interest Expense |
-
| (154) | 154 | 72 | | Income Before Tax | 3,008 | 3,156 | 2,311 | (1,442) | | Income Tax Expense | 1,637 | 624 | 763 | (699) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,371 | 2,532 | 1,547 | (743) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,371 | 2,532 | 1,547 | (743) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,371 | $2,532 | $1,547 | ($743) |
|
0.16% Nasdaq 
0.01 (0.08%) 
Income Statement
